Endocan Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Cost of Goods Sold (COGS) incl. D&A
-
532.40
76.70
-
-
Gross Income
-
532.40
76.70
-
-
SG&A Expense
25.80
40.90
127.40
111.20
743.40
EBIT
25.80
573.30
204.10
111.20
743.40
Unusual Expense
-
465.00
-
1,646.90
600.00
Non Operating Income/Expense
1,125.00
-
-
-
-
Interest Expense
725.70
211.50
5,100.50
222.50
1,968.00
Pretax Income
1,873.00
319.80
5,304.00
1,980.70
3,311.40
Consolidated Net Income
1,873.00
319.80
5,304.00
1,980.70
3,311.40
Net Income
1,873.00
319.80
5,304.00
1,980.70
3,311.40
Net Income After Extraordinaries
631.80
286.30
5,304.00
1,980.70
3,311.40
Net Income Available to Common
3,013.20
319.80
5,304.00
1,980.70
3,311.40
EPS (Basic)
1.40
0.07
0.83
0.11
0.10
Basic Shares Outstanding
2,178.40
5,313.00
6,403.20
17,541.70
32,710.60
EPS (Diluted)
1.48
0.07
0.83
0.11
0.10
Diluted Shares Outstanding
2,178.40
5,313.00
6,403.20
17,541.70
32,710.60
EBITDA
1,082.70
40.90
127.40
111.20
743.40
Non-Operating Interest Income
3.60
-
0.50
-
-
About Endocan
View Profile
